Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
02/2012
02/07/2012CA2511521C Drug delivery from rapid gelling polymer composition
02/07/2012CA2497898C Liquid stable composition of oxazaphosphorine with mesna
02/07/2012CA2497640C Medical device having hydration inhibitor
02/07/2012CA2480826C Oral pharmaceutical formulation in the form of microcapsule aqueous suspension allowing modified release of active ingredient(s)
02/07/2012CA2479057C Compressed tablets comprising microcapsules with modified release
02/07/2012CA2466536C Transdermal transport of compounds
02/07/2012CA2452923C Peptide-based compounds for targeting integrin receptors
02/07/2012CA2340863C Thrombin preparations and process for their production
02/07/2012CA2333147C Cancer treatment methods using antibodies to aminophospholipids
02/02/2012WO2012016188A2 Methods and compositions for delivery of active agents
02/02/2012WO2012016181A2 Anti-allergy lozenges
02/02/2012WO2012016131A1 Nucleophilic catalysts for oxime linkage
02/02/2012WO2012015910A2 Use of adnf polypeptides for treating neurodegenerative diseases
02/02/2012WO2012015325A1 Stabilized immune correction drug viferon-forte for the treatment of infectious inflammatory diseases
02/02/2012WO2012015125A1 Stimulus sensitive magnetic nanocomposite using pyrene polymer, and contrast medium composition containing the nanocomposite
02/02/2012WO2012015043A1 Liquid pharmaceutical composition
02/02/2012WO2012014903A1 Fat-containing composition and oral formulation containing same
02/02/2012WO2012014630A1 Astaxanthin-containing aqueous composition, cosmetic preparation, and method for suppressing degradation of astaxanthin
02/02/2012WO2012014589A1 Adhesive patch for medical use
02/02/2012WO2012014586A1 Adhesive patch for medical use
02/02/2012WO2012014238A1 Composition for the treatment and prevention of herpes simplex labialis
02/02/2012WO2012014046A2 Supramolecular aggregates as drug carriers on cell expressing receptors for branched neurotensin
02/02/2012WO2012013742A2 Stabilization of fsh
02/02/2012WO2012013515A2 Skin patch having optimized active substance release
02/02/2012WO2012013326A1 Complexation of nucleic acids with disulfide-crosslinked cationic components for transfection and immunostimulation
02/02/2012WO2012013117A1 Pharmaceutical composition of temozolomide comprising vitamin c or vitamin c derivative and preparation method thereof
02/02/2012WO2012013116A1 Pharmaceutical composition of temozolomide comprising amino acid stabilizer and preparation method thereof
02/02/2012WO2012013088A1 Dronedarone solid dispersion and preparation method thereof
02/02/2012WO2012012902A1 S-adenosylmethionine formulations with enhanced bioavailability
02/02/2012WO2011156895A3 Porous magnetic nanoparticles and uses thereof formed by incomplete hydrolysis
02/02/2012WO2011129627A3 Docetaxel-loaded thermosensitive liquid suppository composition for rectal administration
02/02/2012WO2011126327A3 Pharmaceutical composition with controlled-release properties comprising mosapride or levodropropizine, and preparing method thereof
02/02/2012WO2011113019A3 Ctla4 proteins and their uses
02/02/2012WO2011109732A3 Reverse thermal gels and uses therefor
02/02/2012WO2011101261A3 Purification method
02/02/2012WO2011091065A8 Synthetic nanostructures including nucleic acids and/or other entities
02/02/2012WO2011069484A3 Dermal, antimicrobial foot cream
02/02/2012US20120029437 Kits for one-dose intradermal delivery for non-live trivalent influenza vaccine
02/02/2012US20120029416 Porous electroactive hydrogels and uses thereof
02/02/2012US20120029091 Method of controlling the release of an active ingredient from a dosage form
02/02/2012US20120029090 Modified alkoxylation products having at least one non-terminal alkoxysilyl group, with increased storage life and increased stretchability of the polymers prepared using them
02/02/2012US20120029089 Preparing biodegradable hydrogel for biomedical application
02/02/2012US20120029017 Pectin-containing jelly formulation
02/02/2012US20120028949 Rapidly Disintegrating Tablet
02/02/2012US20120027879 Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders
02/02/2012US20120027866 Method of preparing a granular delivery system
02/02/2012US20120027838 Filaments comprising an ingestible active agent nonwoven webs and methods for making same
02/02/2012US20120027833 Drug-eluting films
02/02/2012US20120027826 Free-Flowing Emulsion Concentrates
02/02/2012US20120027824 Preparations facilitated by vesicles using alkyl polypentosides and uses of said preparations
02/02/2012US20120027803 Biodegradable lipids for the delivery of active agents
02/02/2012US20120027797 Preservation of Bioactive Materials by Freeze Dried Foam
02/02/2012US20120027796 Novel lipids and compositions for the delivery of therapeutics
02/02/2012US20120027790 Immunological herpes simplex virus antigens and methods for use thereof
02/02/2012US20120027784 Monomethylvaline compounds capable of conjugation to ligands
02/02/2012US20120027783 Monomethylvaline compounds capable of conjugation to ligands
02/02/2012US20120027781 Neuroprotective and neurorestorative method and compositions
02/02/2012US20120027775 Absorbable peg-based hydrogels
02/02/2012US20120027744 Modified heparinase iii and methods of sequencing therewith
02/02/2012US20120027714 Segmented Polymers and Their Conjugates
02/02/2012US20120027698 Cosmetic and/or pharmaceutical composition comprising at least one copolymer comprising at least one ionizable group, and cosmetic treatment process
02/02/2012US20120027695 Water-absorbent adhesive compositions and associated methods of manufacture and use
02/02/2012US20120027694 Inducible release vehicles
02/02/2012US20120027690 Ph-sensitive graft copolymer, manufacturing method for same, and polymer micelles using method
02/02/2012US20120027688 Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
02/02/2012US20120027680 Oxime conjugates and methods for their formation and use
02/02/2012DE19839515B4 Neue pharmazeutische Zubereitung, enthaltend kolloidale Polymer-Wirkstoff-Assoziate, insbesondere auch für mucosale Wirkstoffverabreichung New pharmaceutical preparation containing colloidal polymer-drug associates, especially for mucosal drug delivery
02/02/2012CA2806684A1 Nucleophilic catalysts for oxime linkage
02/02/2012CA2806450A1 Process for the esterification of hyaluronic acid with hydrophobic organic compounds
02/02/2012CA2806399A1 Recombinantly expressed insulin polypeptides and uses thereof
02/02/2012CA2805902A1 Recombinant lectins, binding-site modified lectins and uses thereof
02/02/2012CA2805864A1 Stabilization of fsh
02/02/2012CA2805743A1 Drug-ligand conjugates, synthesis thereof, and intermediates thereto
02/02/2012CA2805739A1 Drug-ligand conjugates, synthesis thereof, and intermediates thereto
02/02/2012CA2804855A1 Pharmaceutical compositions containing pemetrexed having extended storage stability
02/02/2012CA2804847A1 Sirna targeting vegfa and methods for treatment in vivo
02/02/2012CA2804512A1 Fusion proteins of natural human protein fragments to create orderly multimerized immunoglobulin fc compositions
02/02/2012CA2801523A1 Complexation of nucleic acids with disulfide-crosslinked cationic components for transfection and immunostimulation
02/02/2012CA2729798A1 Novel anti-vegf biologics
02/01/2012EP2412758A1 Polyion complex comprising hydrophobized polyamino acid and use of same
02/01/2012EP2412744A2 Method for preparing branched functionalised polymers using branched polyol cores
02/01/2012EP2412386A1 Adhesion preventing composition, solid preparation and method for producing same
02/01/2012EP2412385A1 Liquid formulation of FSH
02/01/2012EP2412377A1 Burdock fruit extract containing arctigenin at high content and process for producing same
02/01/2012EP2412370A1 Matrix-type sustained release preparation containing basic additive
02/01/2012EP2412369A1 Coated solid preparation
02/01/2012EP2412368A1 Method and composition for the treatment of scars
02/01/2012EP2412366A1 Solid preparation
02/01/2012EP2412242A2 Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof
02/01/2012EP2411413A1 Compounds compositions and methods of treating cancer and fibrotic diseases
02/01/2012EP2411056A1 Methods of identifying potential components for targeted drug delivery compositions
02/01/2012EP2411055A2 Determination of tracers within subjects
02/01/2012EP2411054A2 Drug fusions and conjugates
02/01/2012EP2411053A1 A stable iron oligosaccharide compound
02/01/2012EP2411052A2 Carrier comprising a vitamin e derivative
02/01/2012EP2411037A1 Fast-acting insulin formulation
02/01/2012EP2411020A2 Compositions and methods for treatment of hemorrhage
02/01/2012EP2411014A2 A medicinal steroids cream and a process to make it
02/01/2012EP2411013A1 Intraocular sustained release drug delivery systems and methods for treating ocular conditions
02/01/2012EP2411008A1 Compositions comprising water with deuterium for the prevention or treatment of allergic diseases and a process for the preparation thereof
1 ... 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 ... 1712